Description
Experimental Technique/Method:X-RAY DIFFRACTION
Resolution:2.0
Classification:OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR
Release Date:2017-03-15
Deposition Date:2016-11-21
Revision Date:2017-03-22#2017-05-03#2017-11-22
Molecular Weight:115158.14
Macromolecule Type:Protein
Residue Count:980
Atom Site Count:8017
DOI:10.2210/pdb5tz1/pdb
Abstract:
With some advances in modern medicine (such as cancer chemotherapy, broad exposure to antibiotics, and immunosuppression), the incidence of opportunistic fungal pathogens such as
Resolution:2.0
Classification:OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR
Release Date:2017-03-15
Deposition Date:2016-11-21
Revision Date:2017-03-22#2017-05-03#2017-11-22
Molecular Weight:115158.14
Macromolecule Type:Protein
Residue Count:980
Atom Site Count:8017
DOI:10.2210/pdb5tz1/pdb
Abstract:
With some advances in modern medicine (such as cancer chemotherapy, broad exposure to antibiotics, and immunosuppression), the incidence of opportunistic fungal pathogens such as
Date made available | 2017 |
---|---|
Publisher | RCSB-PDB |